The life sciences sector has so far withstood volatility. Here is what lenders and investors are saying could happen next, Rob Murray writes.
10 min read · 01 December 2022
The JLL-arranged loan tracks with regional demand in fast-growing science hub.
2 min read · 13 September 2022
The Colliers-arranged financing underscores the push to convert office space into new uses.
2 min read · 01 September 2022
The speculative Somerville, Massachusetts development is scheduled for completion in 2024.
1 min read · 16 August 2022
Life sciences asset development did not lose momentum through the pandemic thanks to limited supply and a wealth of interest from lenders and investors.
5 min read · 04 August 2022
The New York-based manager believes lenders will be receptive to financing new deals and rehabs in the fast-growing sector.
3 min read · 08 July 2022
Colliers arranged the financing on behalf of the borrower, North River Leerink.
2 min read · 07 July 2022
Boston, San Francisco and San Diego are target areas for future conversion playbook alongside select STEM-friendly markets.
3 min read · 14 June 2022
Respondents see a remarkable revival for the asset class, despite economic and geopolitical headwinds.
2 min read · 08 June 2022
A wave of venture capital investment, increased federal spending and tenant demand for high-quality space is putting the sector under the microscope.
4 min read · 01 February 2022
